BPC-157.

Preclinical recovery standout for soft tissue, gut, and joint support.

RecoveryGut HealthInjurySubcutaneous or intramuscular injection, oral (for gut)

Build a stack with BPC-157 Buy on catalog

Evidence

What the research shows

BPC-157 is the most studied recovery peptide in animal models, with a research profile centered on tissue repair, gut integrity, and faster recovery signaling. The evidence base is still predominantly preclinical: rat and rodent studies consistently point to angiogenesis, growth factor upregulation including VEGF and EGF, and nitric oxide modulation as the core mechanisms behind its popularity. That matters because these pathways sit upstream of the outcomes serious users care about most — blood flow to damaged tissue, collagen remodeling, and a more favorable healing environment. There are no large human randomized controlled trials published yet, so the honest case for BPC-157 is not established clinical efficacy but unusually strong preclinical consistency plus a large volume of user-reported outcomes. Interest is accelerating because few research peptides have built this much momentum in both musculoskeletal and gut-repair circles before human data has fully caught up.

Protocol

Cycle and dosing notes

You start at 250 mcg subcutaneously once daily, with many users placing the injection near the injury site when targeting localized recovery. A more aggressive community protocol is 500 mcg SC daily, typically held for 4 to 12 weeks depending on the research goal. For acute soft-tissue support, 4 to 6 weeks is the most common entry cycle; for more stubborn recovery projects, users often extend to 8 to 12 weeks. After a full cycle, you take a break before restarting rather than running it continuously.

Safety

What to watch for

Generally well tolerated. Avoid if history of cancer due to angiogenic properties.

Best for

Who benefits most

This is for the athlete, lifter, fighter, runner, or high-output operator who is tired of having one irritated tendon, cranky joint, or gut issue dictate training quality. If you want a research compound with a serious reputation in recovery circles — and you understand the difference between compelling animal data and proven human outcomes — BPC-157 fits that mindset.

Not for

Who should avoid it

Not for anyone who is pregnant or breastfeeding, or anyone using it as a substitute for proper medical evaluation of a significant injury, GI bleed, or surgical complication. Avoid use if your clinician has told you not to use injectable research compounds.

Build your stack

BPC-157 works best inside a protocol.

Pepzilla matches it with the right companions, dosing, and lifestyle rails for your goals — calibrated in 60 seconds.

Build my stack Browse encyclopedia